Glycogenolysis is the process by which your body breaks down glycogen, its stored form of sugar, into individual glucose molecules that can be used for energy. It happens mainly in the liver and muscles, and it is one of the primary reasons your blood sugar does not crash between meals or during exercise. The liver releases glucose into the bloodstream for the rest of the body, while muscles keep theirs for local use. That simple division turns out to have far-reaching consequences for everything from how you form memories to why certain rare diseases cause severe exercise intolerance.
How Glycogen Gets Broken Down
Glycogen is a large, highly branched molecule made up of thousands of glucose units linked together. Each glycogen particle, sometimes called a glycosome, functions as an independent metabolic unit with its own set of attached enzymes ready to start or stop breakdown on demand.1PubMed Central. The dynamic life of the glycogen granule The key enzyme that kicks off glycogenolysis is glycogen phosphorylase, which clips glucose units off the outer branches of the glycogen molecule one at a time.2Bentham Science Publishers / Ingenta Connect. Glycogen Phosphorylase Inhibitors Those clipped glucose units come off in a slightly modified form that the cell then converts into a version it can actually feed into energy-producing pathways.
Glycogen phosphorylase can only work on the straight-chain portions of the molecule, though. When it reaches a branch point, a second enzyme called the debranching enzyme takes over. This enzyme does double duty: it transfers a short chain of glucose units from one branch to another, then snips off the remaining single glucose unit at the branch point itself. In mammals, both of these activities reside in a single protein, with different regions of the molecule handling each job.3PubMed. Association of bi-functional activity in the N-terminal domain of glycogen debranching enzyme The two enzymes work in tandem, phosphorylase chewing through the straight chains and the debranching enzyme clearing the way at every fork, until the glycogen particle is whittled down as far as the body needs.
Liver Versus Muscle
The liver and skeletal muscle are both major glycogen warehouses, but they use their stores for completely different purposes, and the biochemistry reflects that. The liver’s job is to maintain blood sugar for the whole body. After glycogen phosphorylase frees glucose units in liver cells, a final enzyme called glucose-6-phosphatase strips off the last chemical tag so that free glucose can be exported into the bloodstream.4PubMed Central. Molecular pathophysiology of hepatic glucose production Between meals and overnight, this process is what keeps your brain, red blood cells, and other glucose-dependent tissues supplied.
Muscle tissue is a different story. Muscle cells contain almost none of the glucose-6-phosphatase enzyme that the liver has in abundance. Studies comparing the two tissues have found that the enzyme’s activity in muscle membranes runs roughly 60 to 100 times lower than in liver, and the messenger RNA that codes for it is present at less than 2% of liver levels.5PubMed Central. Low levels of glucose-6-phosphate hydrolysis in the sarcoplasmic reticulum of skeletal muscle Without that enzyme, muscle cells essentially cannot release free glucose into the bloodstream. Their glycogen is for internal use only, burned on-site to power contraction. This is why depleting your muscle glycogen through exercise does not directly raise your blood sugar the way the liver’s glycogen release does.
The Hormonal On-Off Switch
Glycogenolysis does not run at a constant rate. It is tightly regulated by hormones, and the two main accelerators are glucagon and adrenaline (epinephrine). Glucagon, released by the pancreas when blood sugar drops, primarily targets the liver, telling it to start breaking down glycogen and releasing glucose. Adrenaline, released during stress or exercise, hits both the liver and muscles. Both hormones trigger a cascade inside the cell that ultimately switches glycogen phosphorylase from its inactive form to its active one.
Calcium ions add another layer of control, especially in muscle. When a nerve signal tells a muscle fiber to contract, calcium floods out of storage compartments inside the cell. Researchers discovered that these same low concentrations of calcium simultaneously activate phosphorylase kinase, the enzyme that switches on glycogen phosphorylase. Interestingly, the signaling molecule cyclic AMP, long known as an activator of this pathway, turned out to be ineffective on its own without calcium present; it only amplifies what calcium has already started.6PubMed Central. Regulation of phosphorylase kinase by low concentrations of Ca ions upon muscle contraction This elegant coupling ensures that fuel production ramps up the instant a muscle starts working, without waiting for a hormonal signal to arrive through the blood.
Insulin acts as the brake. After a meal, rising insulin levels signal that glucose is plentiful and glycogen should be built up, not torn down. Insulin works partly through an enzyme called protein phosphatase-1 (PP-1), which flips the key metabolic switches in the opposite direction: it deactivates glycogen phosphorylase while simultaneously activating glycogen synthase, the enzyme that builds glycogen.7PubMed. Protein phosphatase-1 and insulin action In the liver, insulin drives this process through a specific regulatory partner of PP-1 that is itself activated by insulin’s downstream signaling pathway.8PubMed. The Protein Phosphatase 1 Complex Is a Direct Target of AKT that Links Insulin Signaling to Hepatic Glycogen Deposition When this insulin-mediated braking system misfires, as it does in type 2 diabetes, glycogenolysis can continue unchecked even after a meal, contributing to the chronically elevated blood sugar levels that define the disease.
Glycogenolysis in the Brain
The brain stores very little glycogen compared to the liver and muscles, and what it does store sits almost entirely in astrocytes, the star-shaped support cells that surround and nourish neurons. For a long time, this glycogen was considered a minor emergency reserve. Research over the past two decades has changed that view dramatically.
Experiments in rats showed that learning triggers astrocytes to break down their glycogen and release lactate, a metabolic byproduct that neighboring neurons can use as fuel. This lactate turned out to be essential for forming long-term memories. When researchers blocked glycogenolysis in the hippocampus using a drug that inhibits glycogen phosphorylase, long-term memory formation was impaired, but short-term memory was not. Supplying lactate or glucose directly into the hippocampus rescued the memory deficit.9Cell. Astrocytic Glycogenolysis Provides Lactate for Long-Term Memory Formation The same pattern held for spatial working memory: blocking glycogenolysis hurt performance, and providing lactate brought it back.10PLoS ONE. Lactate Produced by Glycogenolysis in Astrocytes Regulates Memory Processing
Follow-up work confirmed that lactate from astrocytic glycogenolysis is not just a backup fuel source but provides a critical energy substrate that neurons require for the molecular machinery of long-term memory formation, including the production of new proteins at synapses.11Communications Biology. Lactate from astrocytes fuels learning-induced mRNA translation in excitatory and inhibitory neurons The picture that has emerged is one where glycogenolysis in astrocytes acts as a rapid energy relay, topping up neuronal fuel exactly when demand spikes during learning. It is a surprising role for what was once considered a simple storage molecule.
Exercise Intensity and Glycogen Use
How fast you burn through muscle glycogen depends overwhelmingly on how hard you are working. Classic exercise physiology research established this in a study that measured glycogen depletion across different exercise intensities. At a light workload of about 31% of maximum aerobic capacity, glycogen use was modest. Bump that up to around 64% of max, and glycogen depletion was roughly 2.7 times greater. At about 84% of max, it was 7.4 times greater. Push past maximum aerobic capacity into truly anaerobic efforts, and the rate climbs even higher.12PubMed Central. Selective glycogen depletion pattern in human muscle fibres after exercise of varying intensity and at varying pedalling rates
This steep curve explains why sprinters and high-intensity athletes care so much about glycogen stores. At low intensities, fat can supply most of the energy, sparing glycogen. As intensity rises, the body shifts increasingly toward glycogenolysis because breaking down glycogen yields energy faster than burning fat does. The “bonk” or “hitting the wall” that endurance athletes dread is essentially the moment when muscle glycogen runs critically low and the body can no longer sustain the pace.
What Happens When Glycogenolysis Goes Wrong
Several inherited diseases directly disrupt glycogenolysis, and they illustrate how essential the process is. Two of the best-studied are McArdle disease and glycogen storage disease type I.
McArdle disease (glycogen storage disease type V) is caused by a deficiency of myophosphorylase, the muscle-specific version of glycogen phosphorylase encoded by the PYGM gene.13PubMed. Genes and exercise intolerance: insights from McArdle disease Without this enzyme, skeletal muscle cannot break down its glycogen at all. People with McArdle disease experience exercise intolerance, painful cramping, and sometimes muscle damage during physical activity, especially during the first few minutes of exertion before alternative fuel sources ramp up.14PubMed Central. McArdle Disease: Insights Into a Rare Metabolic Myopathy in a Young Boy With Recurrent Exercise-Induced Muscle Weakness Many people with the condition learn to pace themselves through the initial discomfort until they reach a “second wind,” a point where blood-borne glucose and fatty acids begin to compensate. The disease was historically understood purely as a glycogenolysis defect, but researchers have noted that the resulting impairment in oxidative metabolism is more significant than was once appreciated.15PubMed. The pathophysiology of McArdle’s disease: clues to regulation in exercise and fatigue
Glycogen storage disease type I (GSD-I) strikes at the last step rather than the first. It involves a deficiency in the glucose-6-phosphatase system, the enzyme complex that allows the liver to release free glucose into the blood. The most common subtype, GSD-Ia, results from mutations in the gene encoding the catalytic part of the enzyme, while GSD-Ib involves the transporter that shuttles the substrate to the enzyme.16PubMed Central. Glucose-6-phosphatase deficiency Because the final step is blocked, the liver can break glycogen down but cannot release the resulting glucose. This leads to poor fasting tolerance, an enlarged liver packed with glycogen and fat, and growth problems in childhood. Interestingly, GSD-Ib also causes low white blood cell counts and immune dysfunction, a connection researchers are still working to fully explain.17PubMed. Type I glycogen storage diseases: disorders of the glucose-6-phosphatase/glucose-6-phosphate transporter complexes
Ketogenic Diets and Glycogenolysis
One of the persistent questions in sports nutrition is what happens to glycogen metabolism when someone follows a very low-carbohydrate or ketogenic diet. The conventional expectation is straightforward: eat fewer carbohydrates, store less glycogen, deplete faster during exercise. Reality turns out to be more nuanced.
A study comparing ultra-endurance runners who had been on a long-term low-carbohydrate diet with matched runners eating a conventional high-carbohydrate diet found something unexpected. Despite dramatic differences in how much fat versus carbohydrate each group burned during exercise, resting muscle glycogen levels were essentially the same in both groups. After three hours of running, both groups depleted their glycogen by about 64%, and after two hours of recovery, both had rebuilt about the same proportion.18PubMed. Metabolic characteristics of keto-adapted ultra-endurance runners The low-carb athletes appeared to maintain their glycogen stores through increased internal recycling and glucose production rather than dietary intake.
Earlier research on obese subjects adapted to a protein-supplemented fast over six weeks found a similar pattern. Resting muscle glycogen initially fell to about 57% of baseline after the first week but climbed back to about 69% by week six, and at that point the subjects could exercise for over four hours of uphill walking without measurably depleting their glycogen stores.19JCI Insight. Capacity for Moderate Exercise in Obese Subjects after Adaptation to a Hypocaloric, Ketogenic Diet The adaptation appeared to involve a wholesale shift toward fat as the dominant fuel, with net carbohydrate use dropping so low that glycogen was largely spared during moderate exercise.
Animal research adds another wrinkle. Rats fed a ketogenic diet showed an enhanced glucose response to epinephrine, meaning their livers were actually more responsive to the hormonal signal that triggers glycogenolysis, and this heightened response was independent of how much glycogen was stored.20PubMed Central. Metabolic switching is impaired by aging and facilitated by ketosis independent of glycogen The takeaway from all of this is that chronically restricting carbohydrates does not simply shut glycogenolysis down. The body adapts its regulatory machinery so that glycogen stores are preserved and mobilized differently, rather than abandoned.
Glycogen Phosphorylase as a Drug Target
Because excessive glycogenolysis in the liver contributes to high blood sugar in type 2 diabetes, pharmacologists have spent decades trying to develop drugs that inhibit glycogen phosphorylase directly. The idea is simple in principle: if the liver is dumping too much glucose between meals, slowing down the enzyme that initiates the process should help. One of the early proof-of-concept compounds, CP-91149, was shown to inhibit human liver glycogen phosphorylase and lower blood glucose in animal models.21PubMed. Discovery of a human liver glycogen phosphorylase inhibitor that lowers blood glucose in vivo
Structural studies of the enzyme revealed that these inhibitors bind at a previously unknown allosteric site, meaning they do not compete directly with the enzyme’s normal substrate but instead alter its shape to reduce its activity. This discovery opened up the possibility of designing more selective drugs with fewer side effects, since allosteric sites tend to be less conserved across different enzymes than the active site is.22PubMed. Human liver glycogen phosphorylase inhibitors bind at a new allosteric site Despite promising early results, no glycogen phosphorylase inhibitor has yet reached widespread clinical use. The challenge lies partly in the redundancy of the system: the liver also produces glucose through gluconeogenesis, a completely separate pathway. Blocking glycogenolysis alone may not be enough to control blood sugar if gluconeogenesis compensates by ramping up, a problem that makes targeting just one pathway less effective than tackling both.
Glycogenolysis Across Species
Glycogenolysis is not unique to humans; virtually every animal that stores glycogen has some version of the same enzymatic machinery. But the evolutionary pressures on that machinery differ in interesting ways depending on an animal’s diet and lifestyle. Fruit bats offer a particularly clean example. Two groups of fruit-eating bats, Old World fruit bats and New World fruit bats, evolved their fruit-based diets independently. Their lineages separated tens of millions of years ago, yet researchers examining the gene for glycogen synthase 2, a key enzyme in glycogen metabolism, found that both groups independently arrived at the same amino acid changes in the protein. Two of these parallel substitutions showed signs of being driven by natural selection rather than random drift.23PubMed. The glycogen synthase 2 gene (Gys2) displays parallel evolution between Old World and New World fruit bats
This kind of convergent molecular evolution suggests that a high-sugar diet creates strong selective pressure on the glycogen system. Bats that eat fruit need to rapidly store large loads of dietary sugar as glycogen and then mobilize it efficiently during flight, which is extremely energy-demanding. The fact that evolution landed on the same molecular solutions in two unrelated bat lineages hints that there are only a limited number of ways to optimize this system, and that even small tweaks to glycogen-related enzymes can confer a meaningful survival advantage when dietary carbohydrate intake is high.